Prognostic factors related to photodynamic therapy for central serous chorioretinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 10, 2009, Pages 1315-1323

  Moon, Jun Woong ^a,d   Yu, Hyeong Gon ^a,b,c   Kim, Tae Wan ^a   Kim, Hyung Chan ^d   Chung, Hum ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Konkuk University Hospital   (South Korea)

Author keywords

Central serous chorioretinopathy; Photodynamic therapy

Indexed keywords

VERTEPORFIN;

ADULT; ARTICLE; ATROPHY; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROGNOSIS; RETINA DETACHMENT; RETINA FOVEA; RETINA INJURY; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RISK ASSESSMENT; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; ATROPHY; CHOROID DISEASES; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FOVEA CENTRALIS; FUNDUS OCULI; HUMANS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROGNOSIS; RETINAL DISEASES; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 69549091725     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1104-8     Document Type: Article

References (31)

1. Gass JD (1967) Pathogenesis of disciform detachment of neuroepithelium: II. Idiopathic central serous chorioretinopathy. Am J Ophthalmol 63:587-615
2. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green angiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057-1062
3. Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121:26-34
4. Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203-213. doi: 10.1097/ 00006982-199616030-00004
5. Klein ML, Van Buskirk EM, Friedman E, Gragoudas E, Chandra S (1974) Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 91:247-250
6. Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE (2002) Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy. Retina 22:19-24. doi: 10.1097/00006982-200202000-00004
7. Iida T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S (2003) Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 23:1-7. doi: 10.1097/00006982-200302000-00001
8. Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87-99. doi: 10.1016/j.ajo.2004.08.037
9. Ficker L, Vafidis G, While A, Leaver P (1988) Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 72:829-834. doi: 10.1136/ bjo.72.11.829
10. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K (1992) Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 2:103-114
11. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235-237. doi: 10.1097/00006982-200304000-00016
12. Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752-763. doi: 10.1097/ 00006982-200312000-00002
13. Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: A pilot study. Retina 23:288-298. doi: 10.1097/ 00006982-200306000-00002
14. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br J Ophthalmol 87:1453-1458. doi: 10.1136/bjo.87.12.1453
15. Ober MD, Yannuzzi LA, Do DV, Spaide RF, Bressler NM, Jampol LM, Angelilli A, Eandi CM, Lyon AT (2005) Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 112:2088-2094. doi: 10.1016/ j.ophtha.2005.06.026
16. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: A short-term pilot study. Br J Ophthalmol 90:869-874. doi: 10.1136/bjo.2006.090282
17. Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: Photodynamic therapy. Am J Ophthalmol 137:1073-1080. doi: 10.1016/j.ajo.2004.01.043
18. Chung SE, Kang JH, Kang SW (2007) Chronic central serous chorioretinopathy: Photodynamic therapy. J Korean Ophthalmol Soc 48:279-284
19. Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133:787-793. doi: 10.1016/ S0002-9394(02)01438-1
20. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H (2002) Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 43:830-841
21. Leem HS, Paik DJ, Kim HC (2007) Morphological analysis of papillary retinal vessels and retinal nerve fiber layer in Koreans. J Korean Ophthalmol Soc 48:1369-1378. doi: 10.3341/jkos.2007.48.10.1369-1378
22. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756-1765. doi: 10.1016/j.ophtha.2008.04.014
23. Bandello F, Virgili G, Lanzetta P, Pirracchio A, Menchini U (2001) ICG angiography and retinal pigment epithelial decompensation (CRSC and epitheliopathy). J Fr Ophtalmol 24:448-451
24. Del Priore LV, Kaplan HJ, Hornbeck R, Jones Z, Swinn M (1996) Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol 122:629-643
25. Del Priore LV, Hornbeck R, Kaplan HJ, Jones Z, Valentino TL, Mosinger-Ogilvie J, Swinn M (1995) Debridement of the pig retinal pigment epithelium in vivo. Arch Ophthalmol 113:939-944
26. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety-enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85-93. doi: 10.1097/ IAE.0b013e318156777f
27. Eandi CM, Chung JE, Piccolino FC, Spaide RF (2005) Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25:417-421. doi: 10.1097/00006982-200506000-00004
28. She H, Nakazawa T, Matsubara A, Hisatomi T, Young TA, Michaud N, Connolly E, Hafezi-Moghadam A, Gragoudas ES, Miller JW (2007) Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 48:2268-2277. doi: 10.1167/iovs.06-0979
29. Reinke MH, Canakis C, Husain D, Michaud N, Flotte TJ, Gragoudas ES, Miller JW (1999) Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 106:1915-1923. doi: 10.1016/S0161-6420(99) 90401-3
30. Song MH, Lee PY, Kim KS, Lee WK (2007) The effect of photodynamic therapy in chronic central serous chorioretinopathy. J Korean Ophthalmol Soc 48:1048-1056. doi: 10.3341/jkos.2007.48.8.1048-1056
31. Olivier S, Harissi-Dagher M, Sebag M (2005) Photodynamic therapy for chronic serous detachment of the retinal pigment epithelium in a young patient. Can J Ophthalmol 40:214-216